ATE241383T1 - Behandlung von allergischen zuständen mit cystein-und serin-proteinase inhibitoren - Google Patents

Behandlung von allergischen zuständen mit cystein-und serin-proteinase inhibitoren

Info

Publication number
ATE241383T1
ATE241383T1 AT98959056T AT98959056T ATE241383T1 AT E241383 T1 ATE241383 T1 AT E241383T1 AT 98959056 T AT98959056 T AT 98959056T AT 98959056 T AT98959056 T AT 98959056T AT E241383 T1 ATE241383 T1 AT E241383T1
Authority
AT
Austria
Prior art keywords
treatment
cystein
proteinase inhibitors
serine proteinase
allergic conditions
Prior art date
Application number
AT98959056T
Other languages
English (en)
Inventor
David Ronald Garrod
Clive Robinson
Original Assignee
Univ Manchester
St Georges Hosp Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester, St Georges Hosp Medical School filed Critical Univ Manchester
Application granted granted Critical
Publication of ATE241383T1 publication Critical patent/ATE241383T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT98959056T 1997-12-11 1998-12-11 Behandlung von allergischen zuständen mit cystein-und serin-proteinase inhibitoren ATE241383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726114.3A GB9726114D0 (en) 1997-12-11 1997-12-11 Prevention and/or treatment of allergic conditions
PCT/GB1998/003721 WO1999029339A2 (en) 1997-12-11 1998-12-11 Prevention and/or treatment of allergic conditions

Publications (1)

Publication Number Publication Date
ATE241383T1 true ATE241383T1 (de) 2003-06-15

Family

ID=10823401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959056T ATE241383T1 (de) 1997-12-11 1998-12-11 Behandlung von allergischen zuständen mit cystein-und serin-proteinase inhibitoren

Country Status (13)

Country Link
US (1) US6440938B1 (de)
EP (1) EP1032415B1 (de)
JP (2) JP2001525374A (de)
AT (1) ATE241383T1 (de)
AU (1) AU747723C (de)
CA (1) CA2313653C (de)
DE (1) DE69815143T2 (de)
ES (1) ES2200394T3 (de)
GB (1) GB9726114D0 (de)
HR (1) HRP20000450A2 (de)
HU (1) HUP0100788A2 (de)
PT (1) PT1032415E (de)
WO (1) WO1999029339A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
US10744179B2 (en) 2014-09-18 2020-08-18 The Provost, Fellows, Foundation Scholars, & the Other Members of Board, of The College of the Holy Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166134A (en) * 1986-12-24 1992-11-24 John Lezdey Treatment of allergic rhinitis
DE69633623T2 (de) * 1995-07-17 2005-12-01 Medivir Uk Ltd. Cystein-Protease-Inhibitoren für die Behandlung von allergischen Krankheiten verursacht duch IgE

Also Published As

Publication number Publication date
AU747723C (en) 2003-10-02
JP2001525374A (ja) 2001-12-11
DE69815143T2 (de) 2004-04-01
GB9726114D0 (en) 1998-02-11
EP1032415A2 (de) 2000-09-06
HRP20000450A2 (en) 2001-06-30
JP2010155831A (ja) 2010-07-15
CA2313653A1 (en) 1999-06-17
DE69815143D1 (de) 2003-07-03
WO1999029339A3 (en) 1999-08-12
HUP0100788A2 (hu) 2001-06-28
ES2200394T3 (es) 2004-03-01
US6440938B1 (en) 2002-08-27
AU747723B2 (en) 2002-05-23
PT1032415E (pt) 2003-09-30
AU1498599A (en) 1999-06-28
WO1999029339A2 (en) 1999-06-17
CA2313653C (en) 2011-02-01
EP1032415B1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
ATE310087T1 (de) Plasma-kallikrein inhibitoren vom kunitz-typ
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
NO20005888D0 (no) Benzimidale derivater som mudulatorer av IgE
ATE520411T1 (de) Behandlung und prävention von lungenerkrankungen
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
ATE439853T1 (de) Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin
NO20061736L (no) Krystallform av epotilon B
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
MEP90508A (en) New pharmaceutical composition
MX9800146A (es) Nuevos inhibidores de trombina, su preparacion y su uso.
ATE345136T1 (de) Cysteinprotease-hemmer mit 2-cyano-4-amino- pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen
NO983688L (no) Serin-protease-inhibitorer
SE9602263D0 (sv) New amino acid derivatives
ATE318606T1 (de) Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i
DK0871454T3 (da) Phosphorholdige inhibitorer af cystein- og serinprotease
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
ATE277943T1 (de) Trypsininhibitoren
YU49422B (sh) Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću
ATE234359T1 (de) Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia
ATE208793T1 (de) Thrombin-inhibitoren
DE60313803D1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
DE69815143D1 (de) Behandlung von allergischen zuständen mit cystein- und serin-proteinase inhibitoren
ATE218877T1 (de) Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties